Sherri Jackson1, Connie Hong2, Erica T Wang2, Carolyn Alexander2, Kimberly D Gregory1, Margareta D Pisarska3. 1. Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California. 2. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California. 3. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: pisarskam@cshs.org.
Abstract
OBJECTIVE: To determine whether there are differences in adverse pregnancy outcomes in very advanced maternal age (vAMA) women who conceived with assisted reproductive technologies (ART) compared with spontaneous conceptions. DESIGN: Retrospective cohort study. SETTING: Academic tertiary care medical center. PATIENT(S): A total of 472 women aged ≥45 years who delivered at one institution. INTERVENTION(S): Mode of conception. MAIN OUTCOME MEASURE(S): Maternal and neonatal outcomes. RESULT(S): For singleton pregnancies, vAMA women who conceived with ART were significantly older (47.0 ± 2.3 vs. 45.6 ± 0.1 years), more likely to be white (88.1% vs. 75.6%), and less parous (0.4 ± 0.9 vs. 1.2 ± 1.8) than vAMA women who conceived spontaneously. They were at significantly increased risk for cesarean delivery (CD) (75.1% vs. 49.7%) and were more likely to undergo elective primary CD without labor (25.4% vs. 9.4%). Risk of retained placenta was also significantly higher (2.7% vs. 0%). Rates of other maternal complications and neonatal outcomes were similar. Subgroup analysis of ART singleton pregnancies did not demonstrate differences in women using autologous oocytes versus donor oocytes. CONCLUSION(S): Very advanced maternal age women who conceive after ART are more likely to be white, older, primiparous, and are more likely to proceed with an elective CD compared with vAMA women who conceive spontaneously. The increased risk of retained placenta in women who conceive with ART may indicate an underlying risk for placentation defects.
OBJECTIVE: To determine whether there are differences in adverse pregnancy outcomes in very advanced maternal age (vAMA) women who conceived with assisted reproductive technologies (ART) compared with spontaneous conceptions. DESIGN: Retrospective cohort study. SETTING: Academic tertiary care medical center. PATIENT(S): A total of 472 women aged ≥45 years who delivered at one institution. INTERVENTION(S): Mode of conception. MAIN OUTCOME MEASURE(S): Maternal and neonatal outcomes. RESULT(S): For singleton pregnancies, vAMAwomen who conceived with ART were significantly older (47.0 ± 2.3 vs. 45.6 ± 0.1 years), more likely to be white (88.1% vs. 75.6%), and less parous (0.4 ± 0.9 vs. 1.2 ± 1.8) than vAMAwomen who conceived spontaneously. They were at significantly increased risk for cesarean delivery (CD) (75.1% vs. 49.7%) and were more likely to undergo elective primary CD without labor (25.4% vs. 9.4%). Risk of retained placenta was also significantly higher (2.7% vs. 0%). Rates of other maternal complications and neonatal outcomes were similar. Subgroup analysis of ART singleton pregnancies did not demonstrate differences in women using autologous oocytes versus donor oocytes. CONCLUSION(S): Very advanced maternal agewomen who conceive after ART are more likely to be white, older, primiparous, and are more likely to proceed with an elective CD compared with vAMAwomen who conceive spontaneously. The increased risk of retained placenta in women who conceive with ART may indicate an underlying risk for placentation defects.
Authors: Joyce A Martin; Brady E Hamilton; Paul D Sutton; Stephanie J Ventura; T J Mathews; Sharon Kirmeyer; Michelle J K Osterman Journal: Natl Vital Stat Rep Date: 2010-08-09
Authors: Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Michelle J K Osterman; Sharon Kirmeyer; T J Mathews; Elizabeth C Wilson Journal: Natl Vital Stat Rep Date: 2011-11-03
Authors: Laura A Schieve; Cynthia Ferre; Herbert B Peterson; Maurizio Macaluso; Meredith A Reynolds; Victoria C Wright Journal: Obstet Gynecol Date: 2004-06 Impact factor: 7.661
Authors: Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Sara J Churchill; Erica T Wang; Marcy Akhlaghpour; Ellen H Goldstein; Dina Eschevarria; Naomi Greene; Matthew Macer; Temeka Zore; John Williams; Margareta D Pisarska Journal: Fertil Steril Date: 2017-05-10 Impact factor: 7.329
Authors: Ning Xu; Gillian M Barlow; Jinrui Cui; Erica T Wang; Bora Lee; Marzieh Akhlaghpour; Lindsay Kroener; John Williams; Jerome I Rotter; Yii-der I Chen; Mark O Goodarzi; Margareta D Pisarska Journal: Reprod Sci Date: 2016-11-14 Impact factor: 3.060
Authors: Erica T Wang; Lauren Ramos; Nina Vyas; Gaisu Bhasin; Charles F Simmons; Margareta D Pisarska Journal: J Matern Fetal Neonatal Med Date: 2018-03-20
Authors: Z Pavlovic; K C Hammer; M Raff; P Patel; K N Kunze; B Kaplan; C Coughlin; J Hirshfeld-Cytron Journal: J Assist Reprod Genet Date: 2020-03-04 Impact factor: 3.412
Authors: Tianyanxin Sun; Bora Lee; Jason Kinchen; Erica T Wang; Tania L Gonzalez; Jessica L Chan; Jerome I Rotter; Yii-Der Ida Chen; Kent Taylor; Mark O Goodarzi; Stephen S Rich; Charles R Farber; John Williams; Margareta D Pisarska Journal: J Clin Endocrinol Metab Date: 2019-04-01 Impact factor: 5.958